Related Experiment Video

Updated: Nov 10, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.6K

Recent Advances in Our Knowledge of mCRC Tumor Biology and Genetics: A Focus on Targeted Therapy Development

William H Gmeiner1

  • 1Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC, USA.

Oncotargets and Therapy
|April 1, 2021
PubMed

Insights

Metastatic colorectal cancer (mCRC) treatment is improving with molecular profiling. Advanced technologies like gene sequencing help personalize therapies by understanding tumor heterogeneity for better patient outcomes.

Area of Science:

  • Oncology
  • Genomics
  • Translational Medicine

Background:

  • Metastatic colorectal cancer (mCRC) is a leading cause of cancer death.
  • Molecular alterations like RAS mutations and microsatellite instability (MSI) guide current mCRC therapies.
  • Tumor heterogeneity presents challenges in treatment selection.

Purpose of the Study:

  • To review recent literature on advanced technologies for characterizing mCRC.
  • To discuss the application of molecular profiling in personalizing mCRC therapies.
  • To explore how understanding tumor biology improves treatment strategies and outcomes.

Main Methods:

  • Review of recent scientific literature on mCRC.
  • Analysis of gene expression profiling, next-generation sequencing, and proteomics.
  • Examination of whole exome sequencing data from primary and metastatic CRC tumors.

Main Results:

  • Advanced technologies provide high-resolution data on tumor molecular profiles.
  • Personalized therapies are increasingly guided by specific tumor biomarkers.
  • Detailed molecular characterization aids in defining mCRC subtypes and heterogeneity.

Conclusions:

  • Molecular profiling and advanced technologies are crucial for advancing mCRC treatment.
  • Personalized therapeutic strategies based on individual tumor biology are improving outcomes.
  • Continued research into tumor heterogeneity will drive the development of more precise mCRC therapies.
Keywords:
colorectal cancermetastasismutationtargeted therapywhole exome sequencing

More Related Videos

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

1.9K
Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

14.1K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.5K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K